Quick Takeaways
- Deep Track Capital, LP filed SCHEDULE 13D for LB Pharmaceuticals Inc Common Stock, $0.0001 par value per share.
- Disclosed ownership: 15%.
- Date of event: 12 Sep 2025.
Deep Track Capital, LP - 12 Sep 2025 SCHEDULE 13D Report for LB Pharmaceuticals Inc Common Stock, $0.0001 par value per share
- Filing Manager
- Deep Track Capital, LP
- Reporting Manager
- Deep Track Capital, LP
- Shares outstanding
- 22,502,040 shares
- Disclosed Ownership
- 3,352,804 shares
- Ownership
- 15%
- Form type
- SCHEDULE 13D
- Filing time
- 19 Sep 2025, 16:30:03 UTC
- Date of event
- 12 Sep 2025
- Previous filing
- 10 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Deep Track Capital, LP disclosed 15% ownership in LB Pharmaceuticals Inc Common Stock, $0.0001 par value per share on 12 Sep 2025."
What Changed
- Previous schedule filing date: 10 Feb 2026.
- Current filing was accepted on 19 Sep 2025, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Biotechnology Master Fund, Ltd. | 12% | 2,686,138 | 0 | 2,686,138 | /s/ David Kroin | David Kroin, Director | |
| Deep Track Special Opportunities Fund, LP | 3% | 666,666 | 0 | 666,666 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Manager | |
| Deep Track Capital, LP | 15% | 3,352,804 | 0 | 3,352,804 | /s/ David Kroin | David Kroin, Managing Member of the General Partner | 0001856083 |
| David Kroin | 15% | 3,352,804 | 0 | 3,352,804 | /s/ David Kroin | David Kroin |